Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada

References

• Canadian Cancer Statistics Steering Committee. Canadian cancer statistics 2010. Toronto. 2010.
   Google Scholar
• Young TK, Kliewer E, Blanchard J, Mayer T. Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada. Am J Public Health. 2000; 90: 1466–8. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Circumpolar Inuit Cancer Review Working Group., Kelly J, Lanier A, Santos M, Healey S, Louchini R, et al.. Cancer among the circumpolar Inuit, 1989–2003. II. Patterns and trends. Int J Circumpolar Health. 2008;67:408–20.
   Web of Science ®Google Scholar
• Kjaer SK, Nielsen NH. Cancer of the female genital tract in Circumpolar Inuit. Acta Oncol. 1996; 35: 581–7. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. Cervical cancer screening in Canada: 1998 surveillance report; 2004. [cited 2012 May 14]. Available from: http://www.phac-aspc.gc.ca/publicat/ccsic-dccuac/chap_5-eng.php.
   Google Scholar
• Hamlin-Douglas LK, Coutlee F, Roger M, Franco EL, Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3141–9. 10.3402/ijch.v72i0.19743.
   Web of Science ®Google Scholar
• Hamlin-Douglas LK, Coutlée F, Roger M, Hanley J, Franco EL, Brassard P, et al.. Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada. Sex Transm Dis. 2010; 37: 377–81.
   Web of Science ®Google Scholar
• Healey SM, Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, et al.. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis. 2001; 28: 694–700. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al.. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009; 10: 321–2. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al.. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12–9.
   PubMed Web of Science ®Google Scholar
• Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al.. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121: 621–32. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al.. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008; 26(Suppl 10): K17–28. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011; 128: 927–35. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al.. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114–9. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Bernard H-U, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM, et al.. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010; 401: 70–9. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Zubach V, Smart G, Ratnam S, Severini A. Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types. J Clin Microbiol. 2012; 50: 460–4. 10.3402/ijch.v72i0.19743.
   Google Scholar
• Goleski V, Dawood M, Ratnam S, Severini A. Luminex®-based assay for multiplex genotyping of 45 mucosal human papillomavirus types. Eurogin 2008 Conference, Nice, France. November 12–15; 2008.
   Google Scholar
• Rebbapragada A, Perusini A, Di Prima A, Salit I, Goleski V, Ratnam S, et al.Evaluation of test performance characteristics and operational parameters of 5 HPV genotyping assays. 26th International Papillomavirus Conference, Montreal, Canada, July 3–8; 2010.
   Google Scholar
• de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al.. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7: 453–9. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al.. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297: 813–9. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Moore RA, Ogilvie G, Fornika D, Moravan V, Brisson M, Amirabbasi-Beik M, et al.. Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccination. Cancer Causes Control. 2009; 20: 1387–96. 10.3402/ijch.v72i0.19743.
   Google Scholar
• Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al.. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ. 2000; 163: 503–8.
   PubMed Web of Science ®Google Scholar
• Kurz J, Mitra K, Adam R, Miao X, MacKay JS, Isa NN, et al.. PCR detection and typing of genital papillomavirus in a New Brunswick population. Int J Cancer. 1993; 55: 604–8. 10.3402/ijch.v72i0.19743.
   Google Scholar
• Demers AA, Shearer B, Severini A, Lotocki R, Kliewer EV, Stopera S, et al.. Distribution of human papillomavirus (HPV) types, cervical cancer screening history, and risk factors for infection in Manitoba (Canada). Chronic Dis Can. 2012; 32: 177–85.
   Google Scholar
• Jiang Y, Brassard P, Severini A, Goleski V, Santos M, Leamon A, et al.. Type-specific prevalence of human papillomavirus infection among women in the Northwest Territories, Canada. J Infect Public Health. 2011; 4: 219–27. 10.3402/ijch.v72i0.19743.
   Google Scholar
• Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al.. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366: 991–8. 10.3402/ijch.v72i0.19743.
   PubMed Web of Science ®Google Scholar
• Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, et al.. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011; 83: 1034–41. 10.3402/ijch.v72i0.19743.
   Google Scholar
• Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monographs. 2003; 31: 14–9. 10.3402/ijch.v72i0.19743.
   PubMedGoogle Scholar
• Bell MC, Schmidt-Grimminger D, Jacobsen A, Chauhan SC, Maher DM, Buchwald DS, et al.. Risk factors for HPV infection among American Indian and white women in the Northern Plains. Gynecol Oncol. 2011; 121: 532–6. 10.3402/ijch.v72i0.19743.
   Google Scholar